• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床人口统计学数据在晚期喉癌生存率中的作用

Role of Clinical-Demographic Data in Survival Rates of Advanced Laryngeal Cancer.

作者信息

Allegra Eugenia, Bianco Maria Rita, Ralli Massimo, Greco Antonio, Angeletti Diletta, de Vincentiis Marco

机构信息

Department of Health Science, University of Catanzaro, 88100 Catanzaro, Italy.

Department of Sense Organs, Sapienza University of Rome, 00185 Rome, Italy.

出版信息

Medicina (Kaunas). 2021 Mar 15;57(3):267. doi: 10.3390/medicina57030267.

DOI:10.3390/medicina57030267
PMID:33804150
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8001944/
Abstract

: Laryngeal cancer is one of the most common cancers in the upper aerodigestive tract, and tobacco and alcohol habits are the most relevant risk factors. The role of these risk factors in the incidence of laryngeal carcinomas is well known, yet only a few studies have been conducted on their role as risk factors of prognosis. The aim of the study was to assess the impact of clinical-demographic data on overall survival (OS), disease-free survival (DFS), and disease-specific survival (DSS) in patients with advanced-stage laryngeal cancer (Stage III-IV) who underwent total laryngectomy. : This retrospective study was carried out on patients with Stage III-IV laryngeal squamous cell carcinoma treated with total laryngectomy between 2004 and 2014. For each patient, clinical and anamnestic data were collected and collated in a database, including alcohol and smoking habits. : Considering the variable age, family history, alcohol, grading, subsite, stage, pT stage, pN stage, and adjuvant therapy, no statistical significance was found for five-year OS. Smoking was the only variable that was statistically significant ( = 0.0043). A relevant difference was noted in the five-year DFS between pN-negative and pN-positive tumors (74.3% vs. 55.26%, respectively; = 0.056), and a statistically significant difference was found between non- and ≤20 cigarettes/day smokers and heavy smokers (77.78% vs. 53.66%, respectively; = 0.021). The five-year disease-specific survival rate was 68.83%, and a significant difference was detected for the smoking and pN stage variables. Heavy smokers (43.90% died vs. 16.67% of the non- and ≤20 cigarettes/day smokers; = 0.0057) and pN-positive (42.1% died vs. 20.51% of the pN-negative patients; = 0.042) patients had a worse prognosis. : Smoking in our study was found to be an important independent risk factor for worse OS and DSS in patients with advanced laryngeal cancer.

摘要

喉癌是上呼吸道消化道最常见的癌症之一,吸烟和饮酒习惯是最相关的风险因素。这些风险因素在喉癌发病率中的作用是众所周知的,但关于它们作为预后风险因素的作用,仅有少数研究。本研究的目的是评估临床人口统计学数据对接受全喉切除术的晚期喉癌(III-IV期)患者总生存期(OS)、无病生存期(DFS)和疾病特异性生存期(DSS)的影响。

这项回顾性研究针对2004年至2014年间接受全喉切除术治疗的III-IV期喉鳞状细胞癌患者开展。为每位患者收集临床和既往史数据,并整理到一个数据库中,包括饮酒和吸烟习惯。

考虑到年龄、家族史、饮酒、分级、亚部位、分期、pT分期、pN分期和辅助治疗等变量,五年总生存期未发现统计学意义。吸烟是唯一具有统计学意义的变量(P = 0.0043)。pN阴性和pN阳性肿瘤的五年无病生存期存在显著差异(分别为74.3%和55.26%;P = 0.056),每天吸烟不超过20支的吸烟者与重度吸烟者之间存在统计学显著差异(分别为77.78%和53.66%;P = 0.021)。五年疾病特异性生存率为68.83%,吸烟和pN分期变量存在显著差异。重度吸烟者(43.90%死亡,而每天吸烟不超过20支的吸烟者为16.67%;P = 0.0057)和pN阳性患者(42.1%死亡,而pN阴性患者为20.51%;P = 0.042)的预后较差。

在我们的研究中,吸烟被发现是晚期喉癌患者总生存期和无病生存期较差的重要独立风险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d38/8001944/1e04f3cc8499/medicina-57-00267-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d38/8001944/66fbf9c3810d/medicina-57-00267-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d38/8001944/357a2aab9b64/medicina-57-00267-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d38/8001944/1e04f3cc8499/medicina-57-00267-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d38/8001944/66fbf9c3810d/medicina-57-00267-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d38/8001944/357a2aab9b64/medicina-57-00267-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d38/8001944/1e04f3cc8499/medicina-57-00267-g003.jpg

相似文献

1
Role of Clinical-Demographic Data in Survival Rates of Advanced Laryngeal Cancer.临床人口统计学数据在晚期喉癌生存率中的作用
Medicina (Kaunas). 2021 Mar 15;57(3):267. doi: 10.3390/medicina57030267.
2
[Clinical analysis of relevant factors causing postoperative recurrence of laryngeal cancer after partial laryngectomy].[喉部分切除术后喉癌复发相关因素的临床分析]
Zhonghua Zhong Liu Za Zhi. 2013 May;35(5):377-81. doi: 10.3760/cma.j.issn.0253-3766.2013.05.012.
3
Lymph Node Density in Node-Positive Laryngeal Carcinoma: Analysis of Prognostic Value for Survival.淋巴结阳性喉癌中的淋巴结密度:生存预后价值分析
Otolaryngol Head Neck Surg. 2016 Nov;155(5):797-804. doi: 10.1177/0194599816652371. Epub 2016 May 24.
4
Survival after laryngectomy: a review of 133 patients with laryngeal carcinoma.喉切除术患者的生存状况:133 例喉癌患者的回顾性研究。
Eur Arch Otorhinolaryngol. 2010 Jul;267(7):1095-101. doi: 10.1007/s00405-009-1156-8. Epub 2009 Nov 18.
5
Management of stage IV glottic carcinoma: therapeutic outcomes.IV期声门癌的治疗:治疗结果
Laryngoscope. 2004 Aug;114(8):1438-46. doi: 10.1097/00005537-200408000-00024.
6
Benefits and drawbacks of open partial horizontal laryngectomies, Part B: Intermediate and selected advanced stage laryngeal carcinoma.开放性部分水平喉切除术的利弊,B部分:中期及特定晚期喉癌
Head Neck. 2016 Apr;38 Suppl 1:E649-57. doi: 10.1002/hed.24064. Epub 2015 Jun 15.
7
Oncological outcomes of surgical treatment for T3 supraglottic laryngeal squamous cell carcinoma patients.T3期声门上型喉鳞状细胞癌患者手术治疗的肿瘤学结局
Acta Otolaryngol. 2018 Nov;138(11):1028-1034. doi: 10.1080/00016489.2018.1490031. Epub 2019 Feb 8.
8
Efficacy of laryngectomy alone for treatment of locally advanced laryngeal cancer: A stage- and subsite-specific survival analysis.单纯喉切除术治疗局部晚期喉癌的疗效:一项基于分期和亚部位的生存分析。
Clin Otolaryngol. 2018 Apr;43(2):544-552. doi: 10.1111/coa.13018. Epub 2017 Nov 21.
9
Metachronous second primary cancers after successful partial laryngectomy for invasive squamous cell carcinoma of the true vocal cord.对于真性声带浸润性鳞状细胞癌成功进行部分喉切除术后发生的异时性第二原发性癌症。
Ann Otol Rhinol Laryngol. 2002 Mar;111(3 Pt 1):204-9. doi: 10.1177/000348940211100303.
10
Comparing surgical and nonsurgical larynx-preserving treatments with total laryngectomy for locally advanced laryngeal cancer.比较局部晚期喉癌全喉切除术与手术和非手术保喉治疗。
Cancer. 2019 Oct 1;125(19):3367-3377. doi: 10.1002/cncr.32292. Epub 2019 Jun 17.

引用本文的文献

1
Laryngeal Cancer in the Modern Era: Evolving Trends in Diagnosis, Treatment, and Survival Outcomes.现代喉癌:诊断、治疗及生存结果的演变趋势
J Clin Med. 2025 May 12;14(10):3367. doi: 10.3390/jcm14103367.
2
Device for Performing Spirometry in Total Laryngectomized Patients.用于全喉切除患者进行肺量测定的装置。
OTO Open. 2024 Oct 30;8(4):e70009. doi: 10.1002/oto2.70009. eCollection 2024 Oct-Dec.
3
Laryngeal Cancer: Epidemiology, Etiology, and Prevention: A Narrative Review.喉癌:流行病学、病因学与预防:一篇叙述性综述

本文引用的文献

1
Tobacco-related cancers in Europe: The scale of the epidemic in 2018.欧洲与烟草相关的癌症:2018 年的疫情规模。
Eur J Cancer. 2020 Nov;139:27-36. doi: 10.1016/j.ejca.2020.07.024. Epub 2020 Sep 18.
2
Updates on larynx cancer epidemiology.喉癌流行病学的最新进展。
Chin J Cancer Res. 2020 Feb;32(1):18-25. doi: 10.21147/j.issn.1000-9604.2020.01.03.
3
Verbal performance of total laryngectomized patients rehabilitated with esophageal speech and tracheoesophageal speech: impacts on patient quality of life.接受食管发音和气管食管发音康复的全喉切除患者的言语表现:对患者生活质量的影响。
Iran J Public Health. 2023 Nov;52(11):2248-2259. doi: 10.18502/ijph.v52i11.14025.
4
Partial Laryngectomy for pT4a Laryngeal Cancer: Outcomes and Limits in Selected Cases.pT4a期喉癌的部分喉切除术:特定病例的治疗结果与局限性
Cancers (Basel). 2023 May 22;15(10):2861. doi: 10.3390/cancers15102861.
5
CD44, PDL1, and ATG7 Expression in Laryngeal Squamous Cell Carcinomas with Tissue Microarray (TMA) Technique: Evaluation of the Potential Prognostic and Predictive Roles.采用组织微阵列(TMA)技术检测喉鳞状细胞癌中CD44、PDL1和自噬相关蛋白7(ATG7)的表达:对潜在预后和预测作用的评估
Cancers (Basel). 2023 Apr 25;15(9):2461. doi: 10.3390/cancers15092461.
6
Olfactory function in laryngectomised patients: tracheo-oesophageal oesophageal speech.喉切除患者的嗅觉功能:气管食管食管言语。
Acta Otorhinolaryngol Ital. 2023 Feb;43(1):20-25. doi: 10.14639/0392-100X-N2253.
7
Experience of individualized nursing in patients with laryngeal squamous cell carcinoma combined with Helicobacter pylori infection after surgery.喉鳞状细胞癌合并幽门螺杆菌感染患者术后个体化护理的体会。
J Cancer Res Clin Oncol. 2023 Aug;149(9):6575-6582. doi: 10.1007/s00432-023-04627-z. Epub 2023 Feb 14.
Psychol Res Behav Manag. 2019 Aug 15;12:675-681. doi: 10.2147/PRBM.S212793. eCollection 2019.
4
Laryngeal Cancer Attributable Factors and the Influence on Survival Rates: A Single Brazilian Institution Experience.喉癌的归因因素及其对生存率的影响:巴西一家机构的单中心经验
Int Arch Otorhinolaryngol. 2019 Jul;23(3):e299-e304. doi: 10.1055/s-0039-1687909. Epub 2019 May 28.
5
Survival analysis of distant metastasis of laryngeal carcinoma: analysis based on SEER database.喉癌远处转移的生存分析:基于监测、流行病学和最终结果(SEER)数据库的分析
Eur Arch Otorhinolaryngol. 2019 Jan;276(1):193-201. doi: 10.1007/s00405-018-5244-5. Epub 2018 Dec 12.
6
Cancer stage and pack-years, but not p16 or HPV, are relevant for survival in hypopharyngeal and laryngeal squamous cell carcinomas.癌症分期和吸烟包年数而非p16或人乳头瘤病毒(HPV)与下咽和喉鳞状细胞癌的生存率相关。
Eur Arch Otorhinolaryngol. 2018 Jul;275(7):1837-1843. doi: 10.1007/s00405-018-4997-1. Epub 2018 May 9.
7
Tobacco smoking and alcohol drinking at diagnosis of head and neck cancer and all-cause mortality: Results from head and neck 5000, a prospective observational cohort of people with head and neck cancer.诊断为头颈部癌症时的吸烟和饮酒与全因死亡率:来自头颈部 5000 的结果,这是对头颈部癌症患者进行的前瞻性观察队列研究。
Int J Cancer. 2018 Sep 1;143(5):1114-1127. doi: 10.1002/ijc.31416. Epub 2018 Apr 23.
8
Association of DNA repair genes polymorphisms and mutations with increased risk of head and neck cancer: a review.DNA 修复基因多态性和突变与头颈部癌症风险增加的关联:综述。
Med Oncol. 2017 Nov 15;34(12):197. doi: 10.1007/s12032-017-1057-4.
9
Alcohol and cigarette consumption predict mortality in patients with head and neck cancer: a pooled analysis within the International Head and Neck Cancer Epidemiology (INHANCE) Consortium.酒精和烟草消费可预测头颈癌患者的死亡率:国际头颈癌流行病学(INHANCE)联盟的汇总分析。
Ann Oncol. 2017 Nov 1;28(11):2843-2851. doi: 10.1093/annonc/mdx486.
10
Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based study.21世纪初在欧洲诊断出的头颈癌的预后与改善情况:基于人群的EUROCARE-5研究
Eur J Cancer. 2015 Oct;51(15):2130-2143. doi: 10.1016/j.ejca.2015.07.043. Epub 2015 Sep 26.